{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:33:38Z","timestamp":1790714018272,"version":"4.1.0"},"reference-count":66,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,7,1]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of reproductive age women characterized in its broadest definition by the presence of oligoamenorrhea and hyperandrogenism and the absence of other disorders. Defects of gonadotropin secretion, including an elevated LH level, elevated LH to FSH ratio, and an increased frequency and amplitude of LH pulsations have been described, but the prevalence of these defects in a large, unbiased population of PCOS patients has not been determined.<\/jats:p>\n               <jats:p>Sixty-one women with PCOS defined by oligomenorrhea and hyperandrogenism and 24 normal women in the early follicular phase had LH samples obtained every 10 min for 8\u201312 h. Pool LH levels from the frequent sampling studies were within the normal range in the 9 PCOS patients (14.8%) who were studied within 21 days after a documented spontaneous ovulation. Excluding these post-ovulatory patients, 75.0% of the PCOS patients had an elevated pool LH level (above the 95th percentile of the normal controls), and 94% had an elevated LH to FSH ratio.<\/jats:p>\n               <jats:p>In the anovulatory PCOS patients, pool LH correlated positively with 17-OH progesterone (R = 0.30, P = 0.03), but not with estradiol, estrone, testosterone, androstenedione, or DHEA-S. Pool LH and LH to FSH ratio correlated positively with LH pulse frequency (R = 0.40, P = 0.004 for pool LH, and R = 0.39; P = 0.005 for LH\/FSH). There was also a strong negative correlation between pool LH and body mass index (BMI) (R = \u22120.59, P &amp;lt; 10\u22125). The relationship between BMI and LH secretion in the PCOS patients appeared to be strongest with body fatness, as pool LH was correlated inversely with percent body fat, whether measured by skinfolds (R= \u22120.61, P &amp;lt; 10\u22125), bioimpedance (R = \u22120.55, P &amp;lt; 10\u22124), or dual energy x-ray absorptiometry (DEXA) (R = \u22120.70, P = 0.001; n = 18 for DEXA only). By DEXA, the only body region that was highly correlated with pool LH was the trunk (R = \u22120.71, P = 0.001).<\/jats:p>\n               <jats:p>The relationship between body fatness and LH secretion occurred via a decrease in LH pulse amplitude (R = \u22120.63, P&amp;lt; 10\u22125 for BMI; R = \u22120.58, P &amp;lt; 10\u22124 for bioimpedance; and R = \u22120.64, P = 0.004 for whole body DEXA), with no significant change in pulse frequency with increasing obesity (R = \u22120.17, P = 0.23 for BMI).<\/jats:p>\n               <jats:p>In conclusion: 1) the prevalence of gonadotropin abnormalities is very high in women with PCOS selected on purely clinical grounds, but is modified by recent spontaneous ovulation; 2) the positive relationship between LH pulse frequency and both pool LH and LH to FSH ratio supports the hypothesis that a rapid frequency of GnRH secretion may play a key etiologic role in the gonadotropin defect in PCOS patients; 3) pool LH and LH pulse amplitude are inversely related to body mass index and percent body fat in a continuous fashion; and 4) the occurrence of a continuous spectrum of gonadotropin abnormalities varying with body fat suggests that nonobese and obese patients with PCOS do not represent distinct pathophysiologic subsets of this disorder.<\/jats:p>","DOI":"10.1210\/jcem.82.7.4105","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:02:00Z","timestamp":1389200520000},"page":"2248-2256","source":"Crossref","is-referenced-by-count":44,"title":["Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1"],"prefix":"10.1210","volume":"82","author":[{"given":"Ann E.","family":"Taylor","sequence":"first","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"McCourt","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Martin","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Adams","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schoenfeld","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Hall","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071623363569400_R1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"2020071623363569400_R2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0015-0282(16)54352-0","article-title":"Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.","volume":"55","author":"Anttila","year":"1991","journal-title":"Fertil Steril"},{"key":"2020071623363569400_R3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycyctic ovary syndrome: clinical, endocrine, and ultrasound features in 556 patients.","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic ovary syndrome: a changing perspective.","volume":"31","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2265.1980.tb02132.x","article-title":"The polycystic ovary syndrome.","volume":"12","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R6","first-page":"165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J. Clin. Endo.","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"Metab"},{"key":"2020071623363569400_R7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1210\/jcem-65-2-233","article-title":"Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome.","volume":"65","author":"Kazer","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1210\/jcem-61-6-1126","article-title":"Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD), and non-PCOD secondary amenorrhea.","volume":"61","author":"Burger","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R9","first-page":"895","article-title":"Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation.","volume":"77","author":"Berga","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1471-0528.1992.tb14505.x","article-title":"Which hormone tests for the diagnosis of polycystic ovary syndrome?","volume":"99","author":"Robinson","year":"1992","journal-title":"Br J Obstet Gyn"},{"key":"2020071623363569400_R11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1990.tb00887.x","article-title":"Hormonal studies on women with polycystic ovaries diagnosed by ultrasound.","volume":"32","author":"Obhrai","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R12","first-page":"240","article-title":"A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation.","volume":"79","author":"Taylor","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/clinchem\/37.3.415","article-title":"Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard.","volume":"37","author":"Vermes","year":"1991","journal-title":"Clin Chim"},{"key":"2020071623363569400_R14","first-page":"1053","article-title":"Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays.","volume":"74","author":"Imse","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia.","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries.","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2020071623363569400_R17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2265.1993.tb02144.x","article-title":"Roles of LH and insulin resistance in non-obese and obese polycystic ovary syndrome.","volume":"38","author":"Grulet","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1990.tb03897.x","article-title":"Effects of luteinizing hormone, insulin, insulin-like growth factor-1, and insulin-like growth factor small binding protein 1 in the polycyctic ovary syndrome.","volume":"33","author":"Conway","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1530\/acta.0.1040110","article-title":"Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.","volume":"104","author":"Pasquali","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071623363569400_R20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(16)55249-2","article-title":"Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovary syndrome: evidence of two distinct populations.","volume":"58","author":"Dale","year":"1992","journal-title":"Fertil Steril"},{"key":"2020071623363569400_R21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03348085","article-title":"Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.","volume":"9","author":"Paradisi","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"2020071623363569400_R22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.1994.tb02578.x","article-title":"The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0028-2243(83)90296-4","article-title":"Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease.","volume":"15","author":"Laatikainen","year":"1983","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020071623363569400_R24","first-page":"388","article-title":"Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels.","volume":"47","author":"Givens","year":"1976","journal-title":"Obstet Gynecol"},{"key":"2020071623363569400_R25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0015-0282(16)59293-0","article-title":"Androgen and Insulin Response to an Oral Glucose Challenge in Hyperandrogenic Women.","volume":"48","author":"Smith","year":"1987","journal-title":"Fertil Steril"},{"key":"2020071623363569400_R26","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in non-obese and obese women with polycyctic ovary syndrome: Common and distinct features.","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-66-1-131","article-title":"The Impact of Obesity and Chronic Hyperinsulinemia on Gonadotropin Release and Gonadal Steroid Secretion in the polycyctic ovary syndrome.","volume":"66","author":"Dunaif","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.","volume":"32","author":"Kiddy,","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623363569400_R29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-64-6-1179","article-title":"Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men.","volume":"64","author":"Spratt","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R30","author":"Zawadzki","year":"1992"},{"key":"2020071623363569400_R31","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"key":"2020071623363569400_R32","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical Assessment of Body Hair Growth in Women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.7326\/0003-4819-103-6-1073","article-title":"Health implications of obesity: National Institutes of Health Consensus Development Conference statement.","volume":"103","year":"1985","journal-title":"Ann Int Med"},{"key":"2020071623363569400_R34"},{"key":"2020071623363569400_R35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1079\/BJN19740060","article-title":"Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.","volume":"32","author":"Durnin","year":"1974","journal-title":"Br J Nutr"},{"key":"2020071623363569400_R36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcn\/48.1.7","article-title":"Specific resistivity used to estimate fat-free mass from segmental body measures of bioelectric ;Impedance.","volume":"48","author":"Chumlea","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"2020071623363569400_R37","first-page":"125","article-title":"Body composition assessment: Dual-energy X-ray absorptiometry (DEXA) compared to reference methods.","volume":"46","author":"Van Loan","year":"1992","journal-title":"Eur J Clin Nutr"},{"key":"2020071623363569400_R38","author":"Filicori","year":"1986"},{"key":"2020071623363569400_R39","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM198005083021903","article-title":"The biologic activity of a potent analogue of gonadotropin-releasing hormone in a normal and hypogonadotropic men.","volume":"302","author":"Crowley","year":"1980","journal-title":"N Engl J Med"},{"key":"2020071623363569400_R40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1172\/JCI111370","article-title":"Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion.","volume":"73","author":"Filicori","year":"1984","journal-title":"J Clin Invest"},{"key":"2020071623363569400_R41","author":"Spratt","year":"1987"},{"key":"2020071623363569400_R42","first-page":"4103","article-title":"Ovarian 17-hydroxyprogesterone hyperresponsiveness to GnRH agonist challenge in women with polycyctic ovary syndrome is not mediated by gonadotropin hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.","volume":"81","author":"Ibanez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R43","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/jcem-72-6-1278","article-title":"Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.","volume":"72","author":"Christman","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jcem-67-2-300","article-title":"Vaginal progesterone ;Administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome.","volume":"67","author":"Buckler","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R45","first-page":"309","article-title":"Pulsatile gonadotropin output in menstrual dysfunction.","volume":"47","author":"Wentz","year":"1976","journal-title":"Obstet Gynecol"},{"key":"2020071623363569400_R46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/jcem-65-6-1164","article-title":"Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with Polycystic Ovarian Disease.","volume":"65","author":"Blankstein","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R47","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0015-0282(16)56751-X","article-title":"Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.","volume":"61","author":"Corenthal","year":"1994","journal-title":"Fertil Steril"},{"key":"2020071623363569400_R48","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-45-4-798","article-title":"Pituitary-ovarian relationships in polycystic ovary syndrome.","volume":"45","author":"Baird","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R49"},{"key":"2020071623363569400_R50"},{"key":"2020071623363569400_R51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess.","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071623363569400_R52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071623363569400_R53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9378(75)90081-2","article-title":"Circulating gonadotropins estrogens, and androgens in Polycystic Ovarian Disease.","volume":"121","author":"DeVane","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"2020071623363569400_R54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/jcem-52-1-156","article-title":"Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.","volume":"52","author":"Lobo","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jcem-54-3-490","article-title":"Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease.","volume":"54","author":"Chang","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R56","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells.","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"2020071623363569400_R57"},{"key":"2020071623363569400_R58","first-page":"4166","article-title":"Serum immunoreactive leptin concentrations in women with polycyctic ovary syndrome.","volume":"81","author":"Brzechffa","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jcem-51-1-26","article-title":"The effects of fasting on serum and urinary gonadotropins in obese postmenopausal women.","volume":"51","author":"Beitins","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1172\/JCI108060","article-title":"Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man.","volume":"56","author":"Pepperell","year":"1975","journal-title":"J Clin Invest"},{"key":"2020071623363569400_R61","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jcem-55-4-654","article-title":"Metabolic clearance rates of luteinizing hormone in women during different phases of the menstrual cycle and while taking an oral contraceptive.","volume":"55","author":"Wehmann","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"2020071623363569400_R64","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycyctic ovary syndrome.","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R65","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623363569400_R66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9378(79)90415-0","article-title":"Gonadotropin profiles in fed and fasted obese women.","volume":"133","author":"Newmark","year":"1979","journal-title":"Am J Obstet Gynecol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/7\/2248\/9233156\/jcem2248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/7\/2248\/9233156\/jcem2248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T13:06:16Z","timestamp":1594991176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/82\/7\/2248\/2866018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7,1]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.82.7.4105","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7,1]]}}}